Agency Information Collection Activities: Proposed Collection; Comment Request, 66990-66993 [2020-23335]
Download as PDF
66990
Federal Register / Vol. 85, No. 204 / Wednesday, October 21, 2020 / Notices
IV. Analysis of and Responses to Public
Comments on the Proposed Notice
In accordance with section
1865(a)(3)(A) of the Act, the May 26,
2020 proposed notice also solicited
public comments regarding whether
TJC’s requirements met or exceeded the
Medicare CfCs for ASCs. No comments
were received in response to our
proposed notice.
khammond on DSKJM1Z7X2PROD with NOTICES
V. Provisions of the Final Notice
A. Differences Between TJC’s Standards
and Requirements for Accreditation and
Medicare Conditions and Survey
Requirements
We compared TJC’s ASC accreditation
requirements and survey process with
the Medicare CfCs of parts 416, and the
survey and certification process
requirements of parts 488 and 489. Our
review and evaluation of TJC’s ASC
application, which were conducted as
described in section III of this final
notice, yielded the following areas
where, as of the date of this notice, TJC
has completed revising its standards
and certification processes in order to
do all of the following:
• Meet the standard’s requirements of
all of the following regulations:
++ Section 416.2, to include the
regulatory definition of an ASC as a
comparable TJC standard instead of a
glossary definition.
++ Section 416.43(c)(2), to address
the broad requirement under the quality
improvement program to track adverse
patient events.
++ Section 416.44(c), to include
reference to the Health Care Facilities
Code (HCFC) of the National Fire
Protection Association (NFPA) 99 (2012
edition).
++ Section 416.45(a), to include
adequate review of credential and
personnel files during survey activity.
++ Section 416.48(a), to include
policies regarding the administration of
drugs be in accordance with acceptable
standards of practice.
++ Section 416.50(a), to provide the
correct regulatory citation reference to
the CMS standard, ‘‘Condition for
Coverage—Patient Rights; Notice of
Rights.’’
++ Section 488.5(a)(4)(iv), to include
the requirement that all comparable
Medicare CfC citations be included in
the findings sections of TJC’s survey
reports.
CMS also reviewed TJC’s comparable
survey processes, which were
conducted as described in section III. of
this final notice, and yielded the
following areas where, as of the date of
this notice, TJC has completed revising
its survey processes in order to
VerDate Sep<11>2014
16:58 Oct 20, 2020
Jkt 253001
demonstrate that it uses survey
processes that are comparable to state
survey agency processes by:
++ Modifying TJC’s accreditation
award letter to facilities to remove the
term ‘‘lengthen’’ to eliminate potential
conflict as it relates to survey cycle
length not to exceed 36 months, as
survey cycles for deeming purposes do
not exceed this timeframe.
++ Adding references to the HCFC of
the NFPA 99 (2012 edition). (NFPA 99)
within its Accreditation Process and
Surveyor Activity Guide.
++ Providing clarification to its
Surveyor Activity Guide indicating that
the 2012 edition of the NFPA Life Safety
Code and NFPA 99 applies to ASCs,
regardless of the number of patients
served.
++ Clarifying the process for TJC’s
performance of on-site Evidence of
Standard Compliance (ESC) processes,
including what it means to provide
coaching and guidance as part of TJC’s
ESC survey activities.
B. Term of Approval
Based on our review described in
section III. and section V. of this final
notice, we approve TJC as a national
accreditation organization for ASCs that
request participation in the Medicare
program. The decision announced in
this final notice is effective December
20, 2020 through December 20, 2024. In
accordance with § 488.5(e)(2)(i) the term
of the approval will not exceed 6 years.
Due to travel restrictions and the
reprioritization of survey activities
brought on by the 2019 Novel
Coronavirus Disease (COVID–19) Public
Health Emergency (PHE), CMS was
unable to observe an ASC survey
completed by TJC surveyors as part of
the application review process, which is
one component of the comparability
evaluation. Therefore, we are providing
TJC with a shorter period of approval.
Based on our discussions with TJC and
the information provided in its
application, we are confident that TJC
will continue to ensure that its
accredited ASCs will continue to meet
or exceed Medicare standards. While
TJC has taken actions based on the
findings annotated in section V.A., of
this final notice, (Differences Between
TJC’s Standards and Requirements for
Accreditation and Medicare Conditions
and Survey Requirements) as authorized
under § 488.8, we will continue ongoing
review of TJC’s ASC survey processes
and will conduct a survey observation
once the COVID–19 PHE has expired. In
keeping with CMS’s initiative to
increase AO oversight broadly, and
ensure that our requested revisions by
TJC are completed, CMS expects more
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
frequent review of TJC’s activities in the
future.
VI. Collection of Information and
Regulatory Impact Statement
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or third
party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
The Administrator of the Centers for
Medicare & Medicaid Services (CMS),
Seema Verma, having reviewed and
approved this document, authorizes
Lynette Wilson, who is the Federal
Register Liaison, to electronically sign
this document for purposes of
publication in the Federal Register.
Dated: October 8, 2020.
Lynette Wilson,
Federal Register Liaison, Department of
Health and Human Services.
[FR Doc. 2020–23230 Filed 10–20–20; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10752, CMS–
10137, CMS–R–262 and CMS–10549]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
SUMMARY:
E:\FR\FM\21OCN1.SGM
21OCN1
Federal Register / Vol. 85, No. 204 / Wednesday, October 21, 2020 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
December 21, 2020.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number lll, Room C4–26–
05, 7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
https://www.cms.gov/Regulations-andGuidance/Legislation/Paperwork
ReductionActof1995/PRA-Listing.html.
2. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10752 Submissions of 1135
Waiver Request Automated Process
CMS–10137 Solicitation for
Applications for Medicare
Prescription Drug Plan 2022 Contracts
CMS–R–262 CMS Plan Benefit
Package (PBP) and Formulary CY
2022
CMS–10549 Generic Clearance:
Questionnaire Testing and
Methodological Research for the
Medicare Current Beneficiary Survey
(MCBS)
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
VerDate Sep<11>2014
16:58 Oct 20, 2020
Jkt 253001
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Submissions of
1135 Waiver Request Automated
Process; Use: Waivers under Section
1135 of the Social Security Act (the Act)
and certain flexibilities allow the CMS
to relax certain requirements, known as
the Conditions of Participation (CoPs) or
Conditions of Coverage to promote the
health and safety of beneficiaries. Under
Section 1135 of the Act, the Secretary
may temporarily waive or modify
certain Medicare, Medicaid, and
Children’s Health Insurance Program
(CHIP) requirements to ensure that
sufficient health care services are
available to meet the needs of
individuals enrolled in Social Security
Act programs in the emergency area and
time periods. These waivers ensure that
providers who provide such services in
good faith can be reimbursed and
exempted from sanctions.
During emergencies, such as the
current COVID–19 public health
emergency (PHE), CMS must be able to
apply program waivers and flexibilities
under section 1135 of the Social
Security Act, in a timely manner to
respond quickly to unfolding events. In
a disaster or emergency, waivers and
flexibilities assist health care providers/
suppliers in providing timely healthcare
and services to people who have been
affected and enables states, Federal
districts, and U.S. territories to ensure
Medicare and/or Medicaid beneficiaries
have continued access to care. During
disasters and emergencies, it is not
uncommon to evacuate Medicareparticipating facilities and relocate
patients/residents to other provider
settings or across state lines, especially,
during hurricane and tornado events.
CMS must collect relevant information
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
66991
for which a provider is requesting a
waiver or flexibility to make proper
decisions about approving or denying
such requests. Collection of this data
aids in the prevention of gaps in access
to care and services before, during, and
after an emergency. CMS must also
respond to inquiries related to a PHE
from providers and beneficiaries. CMS
is not collecting information from these
inquiries; we are merely responding to
them.
Prior to this request, CMS did not
have a standard process or OMB
approval for providers/suppliers
impacted to submit 1135 waiver/
flexibility requests or inquiries, as these
were generally seen on a smaller scale
(natural disasters) prior to the COVID–
19 public health emergency. CMS has
provided general guidance to Medicareparticipating facilities which can be
viewed at https://www.cms.gov/
Medicare/Provider-Enrollment-andCertification/SurveyCertEmergPrep/
1135-Waivers. The requests and
inquiries would be sent directly, via
email, to the Survey Operations Group
in each CMS Location (previously
known as CMS Regional Offices) and
the entity would provide a brief
summary to CMS for a waiver/flexibility
request or an answer to an inquiry. We
are now developing a streamlined,
automated process to standardize the
1135 waiver requests and inquiries
submitted based on lessons learned
during COVID–19 PHE, primarily based
on the volume of requests to ensure
timely response to facility needs. The
waiver request form was approved
under an Emergency information
collection request on October 15, 2020.
Furthermore, the normal operations of
a healthcare provider are disrupted by
emergencies or disasters occasionally.
When this occurs, State Survey
Agencies (SA) deliver a provider/
beneficiary tracking report regarding the
current status of all affected healthcare
providers and their beneficiaries. This
report includes demographic
information about the provider, their
operational status, beneficiary status,
and planned resumption of normal
operations. This information is provided
whether or not a PHE has been declared.
We are now developing a streamlined,
automated process to standardize
submission of this information directly
by the provider during emergencies and
eliminating the need for SA to provide
it. It will consist of a public facing web
form.
This information will be used by CMS
to receive, triage, respond to and report
on requests and/or inquiries for
Medicare, Medicaid, and CHIP
beneficiaries. This information will be
E:\FR\FM\21OCN1.SGM
21OCN1
khammond on DSKJM1Z7X2PROD with NOTICES
66992
Federal Register / Vol. 85, No. 204 / Wednesday, October 21, 2020 / Notices
used to make decisions about approving
or denying waiver and flexibility
requests and may be used to identify
trends that inform CMS Conditions for
Coverage or Conditions for Participation
policies during public health
emergencies, when declared by the
President and the HHS Secretary.
Subsequent to the Emergency
information collection request, we are
revising the package to include a second
form, Healthcare Facility Status
Workflow, which is for operational
status information which will be used to
assist providers in delivering critical
care to beneficiaries during
emergencies. Form Number: CMS–
10752 (OMB control number: 0938–
1384); Frequency: Occasionally;
Affected Public: Private Sector: Business
or other for-profits and Not-for-profit
institutions and State, Local or Tribal
Governments; Number of Respondents:
3,730; Total Annual Responses: 3,730;
Total Annual Hours: 3,730. (For policy
questions regarding this collection,
contact Adriane Saunders at 404–562–
7484.)
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Solicitation for
Applications for Medicare Prescription
Drug Plan 2022 Contracts; Use: Coverage
for the prescription drug benefit is
provided through contracted
prescription drug plans (PDPs) or
through Medicare Advantage (MA)
plans that offer integrated prescription
drug and health care coverage (MA–PD
plans). Cost Plans that are regulated
under Section 1876 of the Social
Security Act, and Employer Group
Waiver Plans (EGWP) may also provide
a Part D benefit. Organizations wishing
to provide services under the
Prescription Drug Benefit Program must
complete an application, negotiate rates,
and receive final approval from CMS.
Existing Part D Sponsors may also
expand their contracted service area by
completing the Service Area Expansion
(SAE) application.
Collection of this information is
mandated in Part D of the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA) in
Subpart 3. The application requirements
are codified in Subpart K of 42 CFR 423
entitled ‘‘Application Procedures and
Contracts with PDP Sponsors.’’
The information will be collected
under the solicitation of proposals from
PDP, MA–PD, Cost Plan, Program of All
Inclusive Care for the Elderly (PACE),
and EGWP applicants. The collected
information will be used by CMS to: (1)
Ensure that applicants meet CMS
requirements for offering Part D plans
VerDate Sep<11>2014
16:58 Oct 20, 2020
Jkt 253001
(including network adequacy,
contracting requirements, and
compliance program requirements, as
described in the application), (2)
support the determination of contract
awards. Form Number: CMS–10137
(OMB control number: 0938–0936);
Frequency: Yearly; Affected Public:
Private Sector: Business or other forprofits and Not-for-profit institutions
and State, Local or Tribal Governments;
Number of Respondents: 658; Total
Annual Responses: 331; Total Annual
Hours: 1,550. (For policy questions
regarding this collection, contact
Arianne Spaccarelli at 410–786–5715.)
3. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: CMS Plan
Benefit Package (PBP) and Formulary
CY 2022; Use: Under the Medicare
Modernization Act (MMA), Medicare
Advantage (MA) and Prescription Drug
Plan (PDP) organizations are required to
submit plan benefit packages for all
Medicare beneficiaries residing in their
service area. The plan benefit package
submission consists of the Plan Benefit
Package (PBP) software, formulary file,
and supporting documentation, as
necessary. MA and PDP organizations
use the PBP software to describe their
organization’s plan benefit packages,
including information on premiums,
cost sharing, authorization rules, and
supplemental benefits. They also
generate a formulary to describe their
list of drugs, including information on
prior authorization, step therapy,
tiering, and quantity limits.
CMS requires that MA and PDP
organizations submit a completed PBP
and formulary as part of the annual
bidding process. During this process,
organizations prepare their proposed
plan benefit packages for the upcoming
contract year and submit them to CMS
for review and approval. CMS uses this
data to review and approve the benefit
packages that the plans will offer to
Medicare beneficiaries. This allows
CMS to review the benefit packages in
a consistent way across all submitted
bids during with incredibly tight
timeframes. This data is also used to
populate data on Medicare Plan Finder,
which allows beneficiaries to access and
compare Medicare Advantage and
Prescription Drug plans. Form Number:
CMS–R–262 (OMB control number:
0938–0763); Frequency: Yearly; Affected
Public: Private Sector: Business or other
for-profits and Not-for-profit institutions
and State, Local or Tribal Governments;
Number of Respondents: 753; Total
Annual Responses: 8,090; Total Annual
Hours: 74,038. (For policy questions
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
regarding this collection, contact Kristy
Holtje at 410–786–2209.)
4. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Generic
Clearance: Questionnaire Testing and
Methodological Research for the
Medicare Current Beneficiary Survey
(MCBS); Use: The current generic
clearance for MCBS Questionnaire
Testing and Methodological Research
encompasses development and testing
of MCBS questionnaires,
instrumentation, and data collection
protocols, as well as a mechanism for
conducting methodological
experiments. The current clearance
includes conducting field tests and
experiments, including split ballot
experiments, within the MCBS
production environment, and
conducting usability tests. The purpose
of this OMB clearance package is to
revise the current clearance to expand
the methods to allow for field tests
outside of MCBS production Field tests
conducted within production do not
incur any additional burden on
respondents whereas tests conducted
outside production must account for
additional respondent burden. The
MCBS is a continuous, multipurpose
survey of a nationally representative
sample of aged, disabled, and
institutionalized Medicare beneficiaries.
The MCBS, which is sponsored by the
Centers for Medicare & Medicaid
Services (CMS), is the only
comprehensive source of information on
the health status, health care use and
expenditures, health insurance
coverage, and socioeconomic and
demographic characteristics of the
entire spectrum of Medicare
beneficiaries. The core of the MCBS is
a series of interviews with a stratified
random sample of the Medicare
population, including aged and disabled
enrollees, residing in the community or
in institutions. Questions are asked
about enrollees’ patterns of health care
use, charges, insurance coverage, and
payments over time. Respondents are
asked about their sources of health care
coverage and payment, their
demographic characteristics, their
health and work history, and their
family living circumstances. In addition
to collecting information through the
core questionnaire, the MCBS collects
information on special topics. Form
Number: CMS–10549 (OMB control
number: 0938–1275); Frequency:
Occasionally; Affected Public:
Individuals or Households; Number of
Respondents: 11,655; Total Annual
Responses: 11,655; Total Annual Hours:
E:\FR\FM\21OCN1.SGM
21OCN1
Federal Register / Vol. 85, No. 204 / Wednesday, October 21, 2020 / Notices
3,947. (For policy questions regarding
this collection, contact William Long at
410–786–7927.)
Dated: October 16, 2020.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2020–23335 Filed 10–20–20; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–116 and CMS–
317]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
Comments on the collection(s) of
information must be received by the
OMB desk officer by November 20,
2020.
khammond on DSKJM1Z7X2PROD with NOTICES
DATES:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
ADDRESSES:
VerDate Sep<11>2014
16:58 Oct 20, 2020
Jkt 253001
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
2. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Clinical
Laboratory Improvement Amendments
(CLIA) Application Form and
Supporting Regulations; Use: Section
353 (b) of the Public Health Service Act
specifies that the laboratory must
submit an application in such form and
manner as the Secretary shall prescribe
that describes the characteristics of the
laboratory and examinations and
procedures performed by the laboratory.
The application must be completed by
entities performing laboratory’s testing
specimens for diagnostic or treatment
purposes. This information is vital to
the certification process. In this
revision, the majority of changes were
minor changes to the form and
accompanying instructions to facilitate
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
66993
the completion and data entry of the
form. We anticipate that the changes
will not increase the time to complete
the form. Form Number: CMS–116
(OMB control number: 0938–0581);
Frequency: Biennially and Occasionally;
Affected Public: Private Sector—
Business or other for-profits and Notfor-profit institutions; Number of
Respondents: 52,140; Total Annual
Responses: 52,140; Total Annual Hours:
52,140. (For policy questions regarding
this collection contact Kathleen Todd at
410–786–3385.)
2. Type of Information Collection
Request: Reinstatement without change
of a previously approved collection of
information; Title of Information
Collection: State Medicaid Eligibility
Quality Control Sampling Plan; Use:
The Medicaid Eligibility Quality Control
(MEQC) program provides states and the
District of Columbia a unique
opportunity to improve the quality and
accuracy of their Medicaid and
Children’s Health Insurance Program
(CHIP) eligibility determinations. The
MEQC program is intended to
complement the Payment Error Rate
Measurement (PERM) program by
ensuring state operations make accurate
and timely eligibility determinations so
that Medicaid and CHIP services are
appropriately provided to eligible
individuals. Current regulations require
that states review equal numbers of
active cases and negative case actions
(i.e., denials and terminations) through
random sampling. Active case reviews
are conducted to determine whether or
not the sampled cases meet all current
criteria and requirements for Medicaid
or CHIP eligibility. Negative case
reviews are conducted to determine if
Medicaid and CHIP denials and
terminations were appropriate and
undertaken in accordance with due
process. Form Number: CMS–317 (OMB
control number: 0938–0146); Frequency:
Occasionally; Affected Public: State,
Local, or Tribal Governments; Number
of Respondents: 10; Total Annual
Responses: 20; Total Annual Hours:
520. (For policy questions regarding this
collection contact Camiel Rowe at 410–
786–0069.)
Dated: October 15, 2020.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2020–23219 Filed 10–20–20; 8:45 am]
BILLING CODE 4120–01–P
E:\FR\FM\21OCN1.SGM
21OCN1
Agencies
[Federal Register Volume 85, Number 204 (Wednesday, October 21, 2020)]
[Notices]
[Pages 66990-66993]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-23335]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-10752, CMS-10137, CMS-R-262 and CMS-10549]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (the PRA), federal agencies are required to publish notice
in the Federal Register concerning each proposed collection of
information (including each proposed extension or reinstatement of an
existing collection of information) and to allow 60 days for public
comment on the proposed action. Interested persons are invited to send
comments regarding our burden estimates or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and
[[Page 66991]]
clarity of the information to be collected, and the use of automated
collection techniques or other forms of information technology to
minimize the information collection burden.
DATES: Comments must be received by December 21, 2020.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number ___, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of following:
1. Access CMS' website address at https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.html.
2. Call the Reports Clearance Office at (410) 786-1326.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-10752 Submissions of 1135 Waiver Request Automated Process
CMS-10137 Solicitation for Applications for Medicare Prescription Drug
Plan 2022 Contracts
CMS-R-262 CMS Plan Benefit Package (PBP) and Formulary CY 2022
CMS-10549 Generic Clearance: Questionnaire Testing and Methodological
Research for the Medicare Current Beneficiary Survey (MCBS)
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collection
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Submissions of
1135 Waiver Request Automated Process; Use: Waivers under Section 1135
of the Social Security Act (the Act) and certain flexibilities allow
the CMS to relax certain requirements, known as the Conditions of
Participation (CoPs) or Conditions of Coverage to promote the health
and safety of beneficiaries. Under Section 1135 of the Act, the
Secretary may temporarily waive or modify certain Medicare, Medicaid,
and Children's Health Insurance Program (CHIP) requirements to ensure
that sufficient health care services are available to meet the needs of
individuals enrolled in Social Security Act programs in the emergency
area and time periods. These waivers ensure that providers who provide
such services in good faith can be reimbursed and exempted from
sanctions.
During emergencies, such as the current COVID-19 public health
emergency (PHE), CMS must be able to apply program waivers and
flexibilities under section 1135 of the Social Security Act, in a
timely manner to respond quickly to unfolding events. In a disaster or
emergency, waivers and flexibilities assist health care providers/
suppliers in providing timely healthcare and services to people who
have been affected and enables states, Federal districts, and U.S.
territories to ensure Medicare and/or Medicaid beneficiaries have
continued access to care. During disasters and emergencies, it is not
uncommon to evacuate Medicare-participating facilities and relocate
patients/residents to other provider settings or across state lines,
especially, during hurricane and tornado events. CMS must collect
relevant information for which a provider is requesting a waiver or
flexibility to make proper decisions about approving or denying such
requests. Collection of this data aids in the prevention of gaps in
access to care and services before, during, and after an emergency. CMS
must also respond to inquiries related to a PHE from providers and
beneficiaries. CMS is not collecting information from these inquiries;
we are merely responding to them.
Prior to this request, CMS did not have a standard process or OMB
approval for providers/suppliers impacted to submit 1135 waiver/
flexibility requests or inquiries, as these were generally seen on a
smaller scale (natural disasters) prior to the COVID-19 public health
emergency. CMS has provided general guidance to Medicare-participating
facilities which can be viewed at https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertEmergPrep/1135-Waivers.
The requests and inquiries would be sent directly, via email, to the
Survey Operations Group in each CMS Location (previously known as CMS
Regional Offices) and the entity would provide a brief summary to CMS
for a waiver/flexibility request or an answer to an inquiry. We are now
developing a streamlined, automated process to standardize the 1135
waiver requests and inquiries submitted based on lessons learned during
COVID-19 PHE, primarily based on the volume of requests to ensure
timely response to facility needs. The waiver request form was approved
under an Emergency information collection request on October 15, 2020.
Furthermore, the normal operations of a healthcare provider are
disrupted by emergencies or disasters occasionally. When this occurs,
State Survey Agencies (SA) deliver a provider/beneficiary tracking
report regarding the current status of all affected healthcare
providers and their beneficiaries. This report includes demographic
information about the provider, their operational status, beneficiary
status, and planned resumption of normal operations. This information
is provided whether or not a PHE has been declared. We are now
developing a streamlined, automated process to standardize submission
of this information directly by the provider during emergencies and
eliminating the need for SA to provide it. It will consist of a public
facing web form.
This information will be used by CMS to receive, triage, respond to
and report on requests and/or inquiries for Medicare, Medicaid, and
CHIP beneficiaries. This information will be
[[Page 66992]]
used to make decisions about approving or denying waiver and
flexibility requests and may be used to identify trends that inform CMS
Conditions for Coverage or Conditions for Participation policies during
public health emergencies, when declared by the President and the HHS
Secretary.
Subsequent to the Emergency information collection request, we are
revising the package to include a second form, Healthcare Facility
Status Workflow, which is for operational status information which will
be used to assist providers in delivering critical care to
beneficiaries during emergencies. Form Number: CMS-10752 (OMB control
number: 0938-1384); Frequency: Occasionally; Affected Public: Private
Sector: Business or other for-profits and Not-for-profit institutions
and State, Local or Tribal Governments; Number of Respondents: 3,730;
Total Annual Responses: 3,730; Total Annual Hours: 3,730. (For policy
questions regarding this collection, contact Adriane Saunders at 404-
562-7484.)
2. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Solicitation for
Applications for Medicare Prescription Drug Plan 2022 Contracts; Use:
Coverage for the prescription drug benefit is provided through
contracted prescription drug plans (PDPs) or through Medicare Advantage
(MA) plans that offer integrated prescription drug and health care
coverage (MA-PD plans). Cost Plans that are regulated under Section
1876 of the Social Security Act, and Employer Group Waiver Plans (EGWP)
may also provide a Part D benefit. Organizations wishing to provide
services under the Prescription Drug Benefit Program must complete an
application, negotiate rates, and receive final approval from CMS.
Existing Part D Sponsors may also expand their contracted service area
by completing the Service Area Expansion (SAE) application.
Collection of this information is mandated in Part D of the
Medicare Prescription Drug, Improvement, and Modernization Act of 2003
(MMA) in Subpart 3. The application requirements are codified in
Subpart K of 42 CFR 423 entitled ``Application Procedures and Contracts
with PDP Sponsors.''
The information will be collected under the solicitation of
proposals from PDP, MA-PD, Cost Plan, Program of All Inclusive Care for
the Elderly (PACE), and EGWP applicants. The collected information will
be used by CMS to: (1) Ensure that applicants meet CMS requirements for
offering Part D plans (including network adequacy, contracting
requirements, and compliance program requirements, as described in the
application), (2) support the determination of contract awards. Form
Number: CMS-10137 (OMB control number: 0938-0936); Frequency: Yearly;
Affected Public: Private Sector: Business or other for-profits and Not-
for-profit institutions and State, Local or Tribal Governments; Number
of Respondents: 658; Total Annual Responses: 331; Total Annual Hours:
1,550. (For policy questions regarding this collection, contact Arianne
Spaccarelli at 410-786-5715.)
3. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: CMS Plan Benefit
Package (PBP) and Formulary CY 2022; Use: Under the Medicare
Modernization Act (MMA), Medicare Advantage (MA) and Prescription Drug
Plan (PDP) organizations are required to submit plan benefit packages
for all Medicare beneficiaries residing in their service area. The plan
benefit package submission consists of the Plan Benefit Package (PBP)
software, formulary file, and supporting documentation, as necessary.
MA and PDP organizations use the PBP software to describe their
organization's plan benefit packages, including information on
premiums, cost sharing, authorization rules, and supplemental benefits.
They also generate a formulary to describe their list of drugs,
including information on prior authorization, step therapy, tiering,
and quantity limits.
CMS requires that MA and PDP organizations submit a completed PBP
and formulary as part of the annual bidding process. During this
process, organizations prepare their proposed plan benefit packages for
the upcoming contract year and submit them to CMS for review and
approval. CMS uses this data to review and approve the benefit packages
that the plans will offer to Medicare beneficiaries. This allows CMS to
review the benefit packages in a consistent way across all submitted
bids during with incredibly tight timeframes. This data is also used to
populate data on Medicare Plan Finder, which allows beneficiaries to
access and compare Medicare Advantage and Prescription Drug plans. Form
Number: CMS-R-262 (OMB control number: 0938-0763); Frequency: Yearly;
Affected Public: Private Sector: Business or other for-profits and Not-
for-profit institutions and State, Local or Tribal Governments; Number
of Respondents: 753; Total Annual Responses: 8,090; Total Annual Hours:
74,038. (For policy questions regarding this collection, contact Kristy
Holtje at 410-786-2209.)
4. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Generic
Clearance: Questionnaire Testing and Methodological Research for the
Medicare Current Beneficiary Survey (MCBS); Use: The current generic
clearance for MCBS Questionnaire Testing and Methodological Research
encompasses development and testing of MCBS questionnaires,
instrumentation, and data collection protocols, as well as a mechanism
for conducting methodological experiments. The current clearance
includes conducting field tests and experiments, including split ballot
experiments, within the MCBS production environment, and conducting
usability tests. The purpose of this OMB clearance package is to revise
the current clearance to expand the methods to allow for field tests
outside of MCBS production Field tests conducted within production do
not incur any additional burden on respondents whereas tests conducted
outside production must account for additional respondent burden. The
MCBS is a continuous, multipurpose survey of a nationally
representative sample of aged, disabled, and institutionalized Medicare
beneficiaries. The MCBS, which is sponsored by the Centers for Medicare
& Medicaid Services (CMS), is the only comprehensive source of
information on the health status, health care use and expenditures,
health insurance coverage, and socioeconomic and demographic
characteristics of the entire spectrum of Medicare beneficiaries. The
core of the MCBS is a series of interviews with a stratified random
sample of the Medicare population, including aged and disabled
enrollees, residing in the community or in institutions. Questions are
asked about enrollees' patterns of health care use, charges, insurance
coverage, and payments over time. Respondents are asked about their
sources of health care coverage and payment, their demographic
characteristics, their health and work history, and their family living
circumstances. In addition to collecting information through the core
questionnaire, the MCBS collects information on special topics. Form
Number: CMS-10549 (OMB control number: 0938-1275); Frequency:
Occasionally; Affected Public: Individuals or Households; Number of
Respondents: 11,655; Total Annual Responses: 11,655; Total Annual
Hours:
[[Page 66993]]
3,947. (For policy questions regarding this collection, contact William
Long at 410-786-7927.)
Dated: October 16, 2020.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2020-23335 Filed 10-20-20; 8:45 am]
BILLING CODE 4120-01-P